Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rhabdomyosarcoma 1Neuroectodermal Tumors 1Chordoma 1Cancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation 1Advanced Solid Tumors 1

Interventions

Oncolytic Virotherapy 2repotrectinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Vincristine 1Thiotepa 1Temozolomide 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Doxorubicin 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Antibodies, Monoclonal 1Amifostine 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Afatinib × Sarcoma × Clear all
NCT02372006 2021-03-04

Trial of Afatinib in Pediatric Tumours

Boehringer Ingelheim

Phase 1/2 Completed
56 enrolled 23 charts
Sarcoma

Rhabdomyosarcoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡